Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
1.
Transfus Apher Sci ; 60(5): 103181, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34238709

RESUMO

INTRODUCTION: Therapeutic plasma exchange (TPE) is an extracorporeal blood purification technique used in a wide spectrum of diseases. We aim to review the indications, complications, and outcomes of critically ill children who received TPE and to compare a membrane versus centrifugal method in this cohort. METHODS: A retrospective observational study in two pediatric intensive care units in Chile during eight years (2011-2019) Results: A total of 36 patients underwent 167 TPE sessions (20 centrifugation and 16 membrane-based). The more frequent indications for TPE were autoimmune neurological diseases in 14 cases, renal diseases (9), and rheumatological disorders (5). 58 % of children received other immunomodulatory therapy. According to ASFA, 45 % of cases were I-II category, 50 % to III, and 5% not classified. Response to treatment was complete in 64 % (23/36) and partial in 33 % (12/36). Complications occurred in 17.4 % of sessions, and the most frequent was transient hypotension during the procedure. Overall survival at discharge from the PICU was 92 %. Patients who received TPE as a single therapy (n = 26) survived 96 %. The clinical outcomes between the two apheresis methods were similar. Survivors had a significantly lower PELOD score on admission (14.5 vs. 6.5, p = 0.004). CONCLUSIONS: TPE is mainly indicated as a rescue treatment in neurological autoimmune diseases refractory to conventional immunomodulatory treatment. Complications in critically ill children are mild and low. The outcome in children requiring TPE as a single therapy is good, and no differences were observed with centrifugation or membrane method.


Assuntos
Cuidados Críticos/métodos , Unidades de Terapia Intensiva Pediátrica , Troca Plasmática/métodos , Doenças Autoimunes/complicações , Doenças Autoimunes/terapia , Remoção de Componentes Sanguíneos , Centrifugação , Criança , Pré-Escolar , Chile , Estado Terminal , Feminino , Humanos , Nefropatias/complicações , Nefropatias/terapia , Masculino , Doenças do Sistema Nervoso/complicações , Doenças do Sistema Nervoso/terapia , Plasmaferese , Estudos Retrospectivos , Doenças Reumáticas/complicações , Doenças Reumáticas/terapia
2.
Pediatr Emerg Care ; 37(1): 44-47, 2021 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-33181794

RESUMO

ABSTRACT: Pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (PIMS-TS) is infrequent, but children might present as a life-threatening disease. In a systematic quantitative review, we analyzed 11 studies of PIMS-TS, including 468 children reported before July 1, 2020. We found a myriad of clinical features, but we were able to describe common characteristics: previously healthy school-aged children, persistent fever and gastrointestinal symptoms, lymphopenia, and high inflammatory markers. Clinical syndromes such as myocarditis and Kawasaki disease were present in only one third of cases each one. Pediatric intensive care unit admission was frequent, although length of stay was less than 1 week, and mortality was low. Most patients received immunoglobulin or steroids, although the level of evidence for that treatment is low. The PIMS-ST was recently described, and the detailed quantitative pooled data will increase clinicians' awareness, improve diagnosis, and promptly start treatment. This analysis also highlights the necessity of future collaborative studies, given the heterogeneous nature of the PIMS-TS.


Assuntos
COVID-19/complicações , SARS-CoV-2 , Síndrome de Resposta Inflamatória Sistêmica/etiologia , Corticosteroides/uso terapêutico , Antibacterianos/uso terapêutico , Anticoagulantes/uso terapêutico , COVID-19/epidemiologia , COVID-19/etiologia , COVID-19/terapia , Criança , Terapia Combinada , Feminino , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Imunossupressores/uso terapêutico , Unidades de Terapia Intensiva Pediátrica/estatística & dados numéricos , Tempo de Internação/estatística & dados numéricos , Masculino , Síndrome de Linfonodos Mucocutâneos/epidemiologia , Síndrome de Linfonodos Mucocutâneos/etiologia , Miocardite/epidemiologia , Miocardite/etiologia , Síndrome de Resposta Inflamatória Sistêmica/tratamento farmacológico , Síndrome de Resposta Inflamatória Sistêmica/epidemiologia , Tratamento Farmacológico da COVID-19
3.
Rev Chil Pediatr ; 90(1): 94-101, 2019.
Artigo em Espanhol | MEDLINE | ID: mdl-31095224

RESUMO

The better understanding of the global activity of vitamin D has led to an intense search for its involvement in non-skeletal diseases. This article presents an updated review of the relationship between vitamin D and pediatric respiratory pathology. A literature search was performed in PUBMED using free terms and MESH terms: vitamin D, asthma, respiratory system diseases, and bronchiolitis. Stu dies in human patients younger than 18 years and animals, published in English and Spanish until 2017 were included. 507 articles were found, of which 43 were included. Indirect evidence suggests a role of vitamin D and fetal lung maturation. In relation to pediatric pulmonary pathology, studies are scarce and inconclusive. Recent meta-analyses performed with individualized evaluation of the participants shows an important protective role of vitamin D supplementation in the prevention of severe asthma exacerbations and acute viral infections. In bronchiolitis, the results are contradictory, with no clear relationship between plasma levels and severity. There is not enough evidence to assess the benefits of vitamin D supplementation in cystic fibrosis and tuberculosis. A direct relationship between the severity of sleep-related breathing disorders and vitamin D plasma levels has recently been proposed, although the exact mechanisms involved in this association are unknown. Current information suggests that vitamin D supplementation may represent a cost-effective strategy in redu cing important causes of infant morbidity and mortality.


Assuntos
Doenças Respiratórias/etiologia , Deficiência de Vitamina D/complicações , Biomarcadores/sangue , Criança , Suplementos Nutricionais , Humanos , Pulmão/embriologia , Pediatria , Doenças Respiratórias/tratamento farmacológico , Doenças Respiratórias/prevenção & controle , Fatores de Risco , Vitamina D/sangue , Vitamina D/fisiologia , Vitamina D/uso terapêutico , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/tratamento farmacológico , Vitaminas/sangue , Vitaminas/fisiologia , Vitaminas/uso terapêutico
4.
Rev Chil Pediatr ; 87(6): 480-486, 2016.
Artigo em Espanhol | MEDLINE | ID: mdl-27381433

RESUMO

INTRODUCTION: Vitamin D is essential for bone health, as well as for cardiovascular and immune function. In critically ill adults vitamin D deficiency (VDD) is common, and is associated with sepsis and higher critical illness severity. OBJECTIVES: To establish the prevalence of VDD and its association with clinically relevant outcomes in children admitted to a Paediatric Intensive Care Unit (PICU) in Concepcion, Chile. PATIENTS AND METHOD: Prospective observational cohort study in 90 consecutive children admitted to the PICU in a university general hospital. Blood was collected on admission to PICU and analysed for 25-OH-D levels. Severity of illness and vasopressor use were assessed using PRISM, PELOD, and vasoactive-inotropic score (VIS) score. VDD was defined as a serum 25-OH-D level<20ng/ml. Relative risks (RR) were calculated to determine the association between VDD and relevant clinical outcomes. RESULTS: Mean (SD) serum vitamin D (25-OH-D) level in the cohort was 22.8 (1.0)ng/ml. The prevalence of VDD was 43.3%. VDD was associated with vasopressors use (RR1.6; 95%CI: 1.2-2.3; P<.01), mechanical ventilation (RR2.2; 95%CI: 1.2-3.9, P<.01), septic shock (RR1.9; 95%CI: 1.3-2.9, P<.001), and fluid bolus>40ml/kg in the first 24h of admission (RR 1.5; 95%CI: 1.1-2.1, P<.05). CONCLUSIONS: In this study, VDD at PICU admission was prevalent in critically ill children and was associated with adverse clinical outcomes. Further studies are needed to assess the potential benefit of optimizing vitamin D status in the PICU.


Assuntos
Vasoconstritores/administração & dosagem , Deficiência de Vitamina D/epidemiologia , Vitamina D/análogos & derivados , Pré-Escolar , Chile , Estudos de Coortes , Estado Terminal , Feminino , Humanos , Unidades de Terapia Intensiva Pediátrica , Masculino , Prevalência , Estudos Prospectivos , Índice de Gravidade de Doença , Vasoconstritores/efeitos adversos , Vitamina D/sangue , Deficiência de Vitamina D/etiologia
6.
Rev Chil Pediatr ; 86(5): 331-6, 2015.
Artigo em Espanhol | MEDLINE | ID: mdl-26320678

RESUMO

INTRODUCTION: The use of biomarkers could be a tool for diagnosis, prognosis and stratifying children with sepsis. Our main goal was to analyze the value of procalcitonin (PCT), C reactive protein (CRP) and lactate in predicting mortality, septic shock and the stratification in children with suspected sepsis PATIENTS AND METHOD: Prospective study in 81 patients. Plasma levels of PCT, CRP and lactate were measured at admission in the pediatric intensive care unit. Patients were categorized into systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock. RESULTS: Concentrations of PCT (ng/mL) increased significantly according to the severity of sepsis: 0.36 (0-1.2) for systemic inflammatory response syndrome; 1.96 (0.4-3.5) for sepsis; 7.5 (3.9-11.1) for severe sepsis; and 58.9 (35.1-82.7) for septic shock (P<.001). Compared to CRP and lactate, the area under the ROC curve revealed a good discriminative power of PCT to predict septic shock and mortality, 0.91 (95% CI: 0.83-0.97) and 0.80 (95% CI: 0.69-0.88), respectively. CONCLUSIONS: In contrast to CRP and lactate, the determination of PCT in pediatric intensive care unit admission is a good predictor of mortality and septic shock and can stratify patients according to severity of sepsis.


Assuntos
Proteína C-Reativa/metabolismo , Calcitonina/sangue , Ácido Láctico/sangue , Sepse/sangue , Biomarcadores , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Unidades de Terapia Intensiva Pediátrica , Masculino , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Sepse/mortalidade , Sepse/fisiopatologia , Índice de Gravidade de Doença , Choque Séptico/sangue , Choque Séptico/diagnóstico , Síndrome de Resposta Inflamatória Sistêmica/sangue , Síndrome de Resposta Inflamatória Sistêmica/fisiopatologia
8.
Rev Chilena Infectol ; 29(5): 511-6, 2012 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-23282492

RESUMO

UNLABELLED: Procalcitonin (PCT), a prohormone of calcitonin has been described as a specific biomarker of sepsis. OBJECTIVES: To compare the predictive value of PCT, C reactive protein (CRP) and white blood cell count (WBC) for the diagnosis of late onset sepsis (LOS) in very low birth weight (VLBW) neonates. METHODS: We prospectively determined the serum concentration of PCT, CRP and WBC in 53 VLBW newborns with clinical suspicion of LOS. 25 had confirmed sepsis with positive blood culture; 28 had clinical sepsis (negative blood cultures) RESULTS: PCT levels were significantly higher in the infected group (3.0 ng/ml) compared to the non infected group (0.4 ng/ml) (p < 0.05). PCT had the highest area under the ROC curve 0.83 (95% CI 0.70-0.92) p = 0.001 compared to CRP 0.51 (95%CI 0.37-0.65) and WBC 0.53 (95%CI 0.38-0.66) for the diagnosis of LOS .The best PCT cut off value was 0.9 ng/ml. The sensitivity, specificity and negative predictive value were 88%, 72% and 87%, respectively. CONCLUSIONS: The determination of PCT could be more useful than CRP and WBC in the diagnosis of LOS in VLBW newborns.


Assuntos
Proteína C-Reativa/análise , Calcitonina/sangue , Recém-Nascido de muito Baixo Peso/sangue , Contagem de Leucócitos , Precursores de Proteínas/sangue , Sepse/diagnóstico , Biomarcadores/sangue , Peptídeo Relacionado com Gene de Calcitonina , Feminino , Humanos , Recém-Nascido , Masculino , Valor Preditivo dos Testes , Estudos Prospectivos , Curva ROC , Sensibilidade e Especificidade , Sepse/sangue
9.
Andes Pediatr ; 93(4): 552-560, 2022 Aug.
Artigo em Espanhol | MEDLINE | ID: mdl-37906854

RESUMO

Acute flaccid myelitis (AFM) is a neuroinflammatory disease characterized by acute asymmetric weakness of the limbs associated with lesions of the gray matter of the spinal cord. It mainly affects children and has been increasingly identified since 2014. OBJECTIVE: To describe a severe emerging neurological disease in Chile. CLINICAL CASE: Three children (2 females), previously healthy were in cluded. The age at the onset was between 4 and 6 years. All presented an acute febrile illness associated with upper respiratory symptoms, rapid onset of proximal asymmetric limb weakness, spinal fluid pleocytosis, and enterovirus isolated from nasopharyngeal swab; two patients developed tetraparesis. The MRI of the spinal cord showed T2 hyperintensity of the grey matter. The three patients were admitted to the Pediatric Intensive Care Unit (PICU), and two required mechanical ventilation. No significant improvements were observed after the use of immunomodulatory therapy and plasma ex change. At 12 months of follow-up, one case was quadriplegic and ventilator-dependent; the second died of ventricular arrhythmia in the PICU, and the third one is under rehabilitation with partial recovery. CONCLUSIONS: We report the first cases of this severe emerging neurological disease in our country. In a child with predominantly proximal and asymmetric acute limb paralysis, pediatricians must have a high index of suspicion for AFM. Since it can progress rapidly and lead to respiratory failure, suspected AFM should be considered a medical emergency.


Assuntos
Viroses do Sistema Nervoso Central , Infecções por Enterovirus , Mielite , Doenças Neuromusculares , Criança , Feminino , Humanos , Pré-Escolar , Doenças Neuromusculares/diagnóstico , Doenças Neuromusculares/terapia , Mielite/diagnóstico , Mielite/terapia , Viroses do Sistema Nervoso Central/complicações , Viroses do Sistema Nervoso Central/diagnóstico , Infecções por Enterovirus/complicações , Infecções por Enterovirus/diagnóstico , Infecções por Enterovirus/terapia
10.
Arch Argent Pediatr ; 120(4): 257-263, 2022 08.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-35900952

RESUMO

INTRODUCTION: Pediatric poisoning is a public health problem worldwide. The objective of this study was to establish the characteristics of pediatric cases of poisoning seen at the pediatric intensive care unit (PICU) of a hospital in Chile. POPULATION AND METHODS: The medical records of patients diagnosed with poisoning and admitted to the PICU between 2013 and 2017 were reviewed. RESULTS: A total of 105 cases were identified, who account for 3% of all admissions recorded in the study period. Patients' median age was 10 years. In total, 73.3% of cases were female patients; 51% of cases were associated with intentional poisoning; and 83% were caused by drug exposure. The most common drugs identified were antidepressants (11.2%) and non-steroidal anti-inflammatory drugs (10.7%). Intake was the most frequent route of exposure (93%). The average length of stay in the PICU was 1.3 days. One patient required intubation and another required hemodialysis in the PICU. Statistically significant relationships were established between patient sex and the circumstance of exposure and between the patient's psychiatric condition and the number of toxic substances ingested. CONCLUSIONS: Most poisoning cases seen at the PICU were intentional and occurred in female patients, who had a psychiatric condition. The most common drugs identified were antidepressants and non-steroidal anti-inflammatory drugs.


Introducción.Las intoxicaciones pediátricas son un problema de salud pública a nivel mundial. El objetivo de este estudio fue caracterizar las intoxicaciones pediátricas que fueron atendidas en la unidad de cuidados intensivos pediátricos (UCIP) de un hospital en Chile. Población y métodos. Se revisaron las fichas clínicas de pacientes diagnosticados con intoxicación e ingresados a la UCIP entre los años 2013 y 2017. Resultados. Un total de 105 casos fueron identificados, lo que representa un 3 % del total de ingresos registrados en el período estudiado. La mediana de edad de los pacientes resultó ser de 10años. El 73,3% de los casos correspondieron a pacientes de sexo femenino. El 51% de los casos se asociaron a intoxicaciones intencionales y el 83% fue causado por exposición a medicamentos. Los medicamentos identificados con mayor frecuencia fueron los antidepresivos (11,2 %), analgésicos no esteroides (10,7 %). La ingesta fue la vía de exposición más común (93 %). El promedio de estadía de los pacientes en UCIP fue de 1,3 días. Dos pacientes ingresaron en la UCI: uno requirió intubación y otro hemodiálisis. Se determinaron relaciones estadísticamente significativas entre el sexo del paciente y la circunstancia de exposición, y entre la condición psiquiátrica del paciente y el número de sustancias tóxicas ingeridas. Conclusión. La mayoría de las intoxicaciones atendidas en la UCIP fueron intencionales y correspondieron a pacientes de sexo femenino, a quienes se les asoció alguna patología psiquiátrica. Los grupos de medicamentos identificados con mayor frecuencia fueron los antidepresivos y los antiinflamatorios no esteroides.


Assuntos
Venenos , Anti-Inflamatórios , Antidepressivos , Criança , Chile/epidemiologia , Feminino , Hospitais , Humanos , Lactente , Unidades de Terapia Intensiva Pediátrica , Masculino , Estudos Retrospectivos
11.
Rev Chilena Infectol ; 28(6): 555-62, 2011 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-22286679

RESUMO

Poultry is a main reservoir and source of human infection in campylobacteriosis. Three hundred and forty one stool samples (291 human, 50 avian) were analyzed. In the human group, 220 samples were collected from children with acute diarrheal disease (183 inpatients, 37 outpatients) and 71 from healthy children. Erythromycin and ciprofloxacin agar dilution MIC tests, Penner serotyping and RAPD-PCR genotyping were performed on 23 strains isolated. C. jejuni was reported only in patients with acute diarrhea (5.4% inpatients, 2.2% outpatients). Campylobacter prevalence in poultry was 34%. Cross-resistance to nalidixic acid and ciprofloxacin was found in 33.3% of human samples and 11.8% of animal samples. Human samples could not be typed using the Penner method. F serotype was the most expressed in poultry. We obtained a total of 14 genotypes (4 / 5 human and 10/15 avian). In conclusion, the predominant species in poultry and humans was C. jejuni, a significant amount of quinolone-resistant human and avian samples were obtained, and avian genotypes and serotypes were not found in human samples. The latter would mean that another source of infection could exist; therefore other reservoirs must be studied.


Assuntos
Antibacterianos/farmacologia , Campylobacter coli/efeitos dos fármacos , Campylobacter jejuni/efeitos dos fármacos , Fezes/microbiologia , Aves Domésticas/microbiologia , Doença Aguda , Adolescente , Animais , Campylobacter coli/genética , Campylobacter coli/isolamento & purificação , Campylobacter jejuni/genética , Campylobacter jejuni/isolamento & purificação , Criança , Pré-Escolar , Diarreia/microbiologia , Genótipo , Humanos , Lactente , Recém-Nascido , Técnica de Amplificação ao Acaso de DNA Polimórfico
14.
Front Pediatr ; 9: 756083, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34869111

RESUMO

Importance: Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection is thought to be driven by a post-viral dysregulated immune response, where interleukin 6 (IL-6) might have a central role. In this setting, IL-6 inhibitors are prescribed as immunomodulation in cases refractory to standard therapy. Objective: To compare plasma IL-6 concentration between critically ill children with MIS-C and sepsis. Design: A retrospective cohort study from previously collected data. Setting: Individual patient data were gathered from three different international datasets. Participants: Critically ill children between 1 month-old and 18 years old, with an IL-6 level measured within 48 h of admission to intensive care. Septic patients were diagnosed according to Surviving Sepsis Campaign definition and MIS-C cases by CDC criteria. We excluded children with immunodeficiency or immunosuppressive therapy. Exposure: None. Main Outcome(s) and Measure(s): The primary outcome was IL-6 plasma concentration in MIS-C and sepsis group at admission to the intensive care unit. We described demographics, inflammatory biomarkers, and clinical outcomes for both groups. A subgroup analysis for shock in each group was done. Results: We analyzed 66 patients with MIS-C and 44 patients with sepsis. MIS-C cases were older [96 (48, 144) vs. 20 (5, 132) months old, p < 0.01], but no differences in sex (41 vs. 43% female, p = 0.8) compared to septic group. Mechanical ventilation use was 48.5 vs. 93% (p < 0.001), vasoactive drug use 79 vs. 66% (p = 0.13), and mortality 4.6 vs. 34.1% (p < 0.01) in MIS-C group compared to sepsis. IL-6 was 156 (36, 579) ng/dl in MIS-C and 1,432 (122, 6,886) ng/dl in sepsis (p < 0.01), while no significant differences were observed in procalcitonin (PCT) and c-reactive protein (CRP). 52/66 (78.8%) patients had shock in MIS-C group, and 29/44 (65.9%) had septic shock in sepsis group. Septic shock had a significantly higher plasma IL-6 concentration than the three other sub-groups. Differences in IL-6, CRP, and PCT were not statistically different between MIS-C with and without shock. Conclusions and Relevance: IL-6 plasma concentration was elevated in critically ill MIS-C patients but at levels much lower than those of sepsis. Furthermore, IL-6 levels don't discriminate between MIS-C cases with and without shock. These results lead us to question the role of IL-6 in the pathobiology of MIS-C, its diagnosis, clinical outcomes, and, more importantly, the off-label use of IL-6 inhibitors for these cases.

15.
Rev Chilena Infectol ; 27(5): 413-6, 2010 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-21186507

RESUMO

Since the World Health Organization declared a pandemic of a novel influenza A (H1N1) virus, much attention has been focused on its respiratory manifestations, but limited information regarding neurologic complications has been reported in children. We describe a case of acute encephalopathy progressing to brain death in a pediatric patient with confirmed infection with novel influenza A (H1N1).


Assuntos
Morte Encefálica , Encefalopatias/virologia , Viroses do Sistema Nervoso Central/virologia , Vírus da Influenza A Subtipo H1N1/isolamento & purificação , Influenza Humana/complicações , Doença Aguda , Criança , Chile/epidemiologia , Evolução Fatal , Humanos , Influenza Humana/diagnóstico , Masculino , Tomografia Computadorizada por Raios X
16.
Rev Chilena Infectol ; 26(2): 152-5, 2009 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-19621147

RESUMO

Necrotizing fasciitis (NF) is a serious infection that compromises subcutaneous tissue, fascia, and adipose tissue, with high mortality rate and sequelae. Extremities, trunk and pelvis are the most common body sites affected. Periorbital celullitis with necrotizing fasciitis of the eyelid is rare. We report the case of a three years oíd child with bilateral NF of the eyelids and toxic shock syndrome secondary to Streptococcus pyogenes infection occurring after a minor skin trauma. Early recognition leading to intensive care treatment and prompt surgical debridement were critical in the favourable outcome of the child.


Assuntos
Doenças Palpebrais/terapia , Fasciite Necrosante/terapia , Choque Séptico/terapia , Infecções Estreptocócicas/tratamento farmacológico , Streptococcus pyogenes , Antibacterianos/uso terapêutico , Pré-Escolar , Terapia Combinada , Desbridamento , Doenças Palpebrais/diagnóstico , Doenças Palpebrais/microbiologia , Fasciite Necrosante/diagnóstico , Fasciite Necrosante/etiologia , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Masculino , Índice de Gravidade de Doença , Choque Séptico/diagnóstico , Choque Séptico/microbiologia , Infecções Estreptocócicas/diagnóstico , Streptococcus pyogenes/isolamento & purificação , Resultado do Tratamento
17.
Arch. argent. pediatr ; 120(4): 257-263, Agosto 2022. tab
Artigo em Inglês, Espanhol | LILACS, BINACIS | ID: biblio-1371844

RESUMO

Introducción. Las intoxicaciones pediátricas son un problema de salud pública a nivel mundial. El objetivo de este estudio fue caracterizar las intoxicaciones pediátricas que fueron atendidas en la unidad de cuidados intensivos pediátricos (UCIP) de un hospital en Chile. Población y métodos. Se revisaron las fichas clínicas de pacientes diagnosticados con intoxicación e ingresados a la UCIP entre los años 2013 y 2017. Resultados. Un total de 105 casos fueron identificados, lo que representa un 3 % del total de ingresos registrados en el período estudiado. La mediana de edad de los pacientes resultó ser de 10 años. El 73,3 % de los casos correspondieron a pacientes de sexo femenino. El 51 % de los casos se asociaron a intoxicaciones intencionales y el 83 % fue causado por exposición a medicamentos. Los medicamentos identificados con mayor frecuencia fueron los antidepresivos (11,2 %), analgésicos no esteroides (10,7 %). La ingesta fue la vía de exposición más común (93 %). El promedio de estadía de los pacientes en UCIP fue de 1,3 días. Dos pacientes ingresaron en la UCI: uno requirió intubación y otro hemodiálisis. Se determinaron relaciones estadísticamente significativas entre el sexo del paciente y la circunstancia de exposición, y entre la condición psiquiátrica del paciente y el número de sustancias tóxicas ingeridas. Conclusión. La mayoría de las intoxicaciones atendidas en la UCIP fueron intencionales y correspondieron a pacientes de sexo femenino, a quienes se les asoció alguna patología psiquiátrica. Los grupos de medicamentos identificados con mayor frecuencia fueron los antidepresivos y los antiinflamatorios no esteroides.


Introduction. Pediatric poisoning is a public health problem worldwide. The objective of this study was to establish the characteristics of pediatric cases of poisoning seen at the pediatric intensive care unit (PICU) of a hospital in Chile. Population and methods. The medical records of patients diagnosed with poisoning and admitted to the PICU between 2013 and 2017 were reviewed. Results. A total of 105 cases were identified, who account for 3% of all admissions recorded in the study period. Patients' median age was 10 years. In total, 73.3% of cases were female patients; 51% of cases were associated with intentional poisoning; and 83% were caused by drug exposure. The most common drugs identified were antidepressants (11.2%) and non-steroidal anti-inflammatory drugs (10.7%). Intake was the most frequent route of exposure (93%). The average length of stay in the PICU was 1.3 days. One patient required intubation and another required hemodialysis in the PICU. Statistically significant relationships were established between patient sex and the circumstance of exposure and between the patient's psychiatric condition and the number of toxic substances ingested. Conclusion. Most poisoning cases seen at the PICU were intentional and occurred in female patients, who had a psychiatric condition. The most common drugs identified were antidepressants and non-steroidal antiinflammatory drugs.


Assuntos
Humanos , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Venenos , Unidades de Terapia Intensiva Pediátrica , Chile/epidemiologia , Estudos Retrospectivos , Hospitais , Anti-Inflamatórios , Antidepressivos
18.
Rev Chilena Infectol ; 23(1): 73-6, 2006 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-16462969

RESUMO

Subdural empyema is a rare complication of sinusitis in children. Its clinical presentation represents a neurosurgical emergency and as a scarcely recognized entity a delayed diagnosis rapidly increases its fatal prognosis. We report the clinical and radiological course of an adolescent with a subdural empyema secondary to sinusitis. Clinical and radiological features, laboratory findings and outcome of this condition are discussed based in a review of previously reported cases.


Assuntos
Empiema Subdural/etiologia , Sinusite/complicações , Criança , Craniotomia , Empiema Subdural/diagnóstico , Empiema Subdural/cirurgia , Humanos , Masculino , Sinusite/diagnóstico , Sinusite/cirurgia , Tomografia Computadorizada por Raios X
19.
Rev. chil. pediatr ; 90(1): 94-101, 2019. tab
Artigo em Espanhol | LILACS | ID: biblio-990891

RESUMO

Resumen: El mejor entendimiento sobre la actividad global de la vitamina D, ha llevado a una intensa búsque da de sus implicancias en enfermedades no esqueléticas. En este artículo se presenta una revisión actualizada de la relación entre la vitamina D y la patología respiratoria pediátrica. Se realizó una búsqueda bibliográfica en PUBMED utilizando términos libres y MESH: vitamina D, enfermedades del sistema respiratorio, asma, bronquiolitis. Se seleccionó estudios en humanos menores de 18 años y animales, publicados en inglés y español hasta el 2017. Se encontraron 507 artículos, de los cuales se incluyeron 43. Evidencia indirecta apunta hacia un rol de la vitamina D y la maduración pulmonar fetal. En relación a la patología pulmonar pediátrica, los estudios son escasos y poco concluyentes. Nuevos meta - análisis, con evaluación individualizada de los participantes, muestran un importante rol protector de la suplementación en la prevención de exacerbaciones asmáticas severas e infecciones virales agudas. En bronquiolitis los resultados son contradictorios, sin relación clara entre niveles plasmáticos y severidad. No existe suficiente evidencia que evalué los beneficios en fibrosis quística y tuberculosis. Recientemente se ha propuesto una relación directa entre la severidad de los trastornos respiratorios del sueño y los niveles plasmáticos de vitamina D, aunque se desconoce los mecanismos exactos involucrados a esta asociación. La información actual permite suponer que la suplementación de vitamina D puede representar una estrategia costo - efectiva en la reducción de importantes causas de morbimortalidad infantil.


Abstract: The better understanding of the global activity of vitamin D has led to an intense search for its involvement in non-skeletal diseases. This article presents an updated review of the relationship between vitamin D and pediatric respiratory pathology. A literature search was performed in PUBMED using free terms and MESH terms: vitamin D, asthma, respiratory system diseases, and bronchiolitis. Stu dies in human patients younger than 18 years and animals, published in English and Spanish until 2017 were included. 507 articles were found, of which 43 were included. Indirect evidence suggests a role of vitamin D and fetal lung maturation. In relation to pediatric pulmonary pathology, studies are scarce and inconclusive. Recent meta-analyses performed with individualized evaluation of the participants shows an important protective role of vitamin D supplementation in the prevention of severe asthma exacerbations and acute viral infections. In bronchiolitis, the results are contradictory, with no clear relationship between plasma levels and severity. There is not enough evidence to assess the benefits of vitamin D supplementation in cystic fibrosis and tuberculosis. A direct relationship between the severity of sleep-related breathing disorders and vitamin D plasma levels has recently been proposed, although the exact mechanisms involved in this association are unknown. Current information suggests that vitamin D supplementation may represent a cost-effective strategy in redu cing important causes of infant morbidity and mortality.


Assuntos
Humanos , Criança , Doenças Respiratórias/etiologia , Deficiência de Vitamina D/complicações , Pediatria , Doenças Respiratórias/prevenção & controle , Doenças Respiratórias/tratamento farmacológico , Vitamina D/fisiologia , Vitamina D/sangue , Vitamina D/uso terapêutico , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/tratamento farmacológico , Deficiência de Vitamina D/sangue , Vitaminas/fisiologia , Vitaminas/sangue , Vitaminas/uso terapêutico , Biomarcadores/sangue , Fatores de Risco , Suplementos Nutricionais , Pulmão/embriologia
20.
Neumol. pediátr. (En línea) ; 11(2): 65-70, abr. 2016. tab
Artigo em Espanhol | LILACS | ID: biblio-835062

RESUMO

Viral bronchiolitis is a major worldwide cause of morbidity and mortality in children under two years old. Evidence-based management guidelines suggest that there is no effective treatment for bronchiolitis and that supportive care - hydration and oxygenation - remains the cornerstone of clinical management. In this review we describe the current guidelines of treatment with emphasis in the limitation of unnecessary testing and intervention. Also, we discuss the future directions in the research of new therapies for bronchiolitis.


La bronquiolitis viral es una causa importante de morbilidad y mortalidad en niños de menos de dos años de edad en todo el mundo. Las guías clínicas basadas en la evidencia sugieren que no existe un tratamiento efectivo para la bronquiolitis y que la hidratación y una adecuada oxigenación, siguen siendo la base del manejo clínico. En esta revisión, se describen las actuales guías de tratamiento haciendo énfasis en limitar los exámenes e intervenciones innecesarias. También discutimos la investigación en nuevas terapias para la bronquiolitis.


Assuntos
Humanos , Criança , Bronquiolite Viral/terapia , Doença Aguda , Broncodilatadores/uso terapêutico , Bronquiolite Viral/diagnóstico , Bronquiolite Viral/etiologia , Bronquiolite Viral/fisiopatologia , Epinefrina/uso terapêutico , Guias como Assunto , Oxigenoterapia , Guias de Prática Clínica como Assunto , Vírus Sinciciais Respiratórios
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA